Document Detail


Addition of an indoleamine 2,3,-dioxygenase inhibitor to B cell-depletion therapy blocks autoreactive B cell activation and recurrence of arthritis in K/BxN mice.
MedLine Citation:
PMID:  22294267     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To define the role of indoleamine 2,3-dioxygenase (IDO) in driving pathogenic B cell responses that lead to arthritis and to determine if inhibitors of the IDO pathway can be used in conjunction with therapeutic B cell depletion to prevent the reemergence of autoantibodies and arthritis following reconstitution of the B cell repertoire.
METHODS: Immunoglobulin-transgenic mice were treated with the IDO inhibitor 1-methyltryptophan (1-MT) and monitored for the extent of autoreactive B cell activation. Arthritic K/BxN mice were treated with B cell depletion alone or in combination with 1-MT. Mice were monitored for the presence of autoantibody-secreting cells, inflammatory cytokines, and joint inflammation.
RESULTS: Treatment with 1-MT did not affect the initial activation or survival of autoreactive B cells, but it did inhibit their ability to differentiate into autoantibody-secreting cells. Treatment with anti-CD20 depleted the B cell repertoire and attenuated arthritis symptoms; however, the arthritis symptoms rapidly returned as B cells repopulated the repertoire. Administration of 1-MT prior to B cell repopulation prevented the production of autoantibodies and inflammatory cytokines and flare of arthritis symptoms.
CONCLUSION: IDO activity is essential for the differentiation of autoreactive B cells into antibody-secreting cells, but it is not necessary for their initial stages of activation. Addition of 1-MT to therapeutic B cell depletion prevents the differentiation of autoantibody-secreting cells and the recurrence of autoimmune arthritis following reconstitution of the B cell repertoire. These data suggest that IDO inhibitors could be used in conjunction with B cell depletion as an effective cotherapeutic strategy in the treatment of rheumatoid arthritis.
Authors:
Elizabeth Pigott; Laura Mandik-Nayak
Related Documents :
2823717 - Cell-cycle dependence of dolichyl phosphate biosynthesis.
2441047 - Novel nucleolar antigens in autoimmune disease.
8380637 - Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein...
11341787 - Frap-p70s6k signaling is required for pancreatic cancer cell proliferation.
221667 - Unstable resistance of g mouse fibroblasts to ecotropic murine leukemia virus infection.
333447 - Cell cycle of saccharomycescerevisiae in populations growing at different rates.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Arthritis and rheumatism     Volume:  64     ISSN:  1529-0131     ISO Abbreviation:  Arthritis Rheum.     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-06-28     Completed Date:  2012-09-14     Revised Date:  2013-04-16    
Medline Journal Info:
Nlm Unique ID:  0370605     Medline TA:  Arthritis Rheum     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2169-78     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2012 by the American College of Rheumatology.
Affiliation:
Lankenau Institute for Medical Research, Wynnewood, Pennsylvania 19096, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Arthritis, Experimental / drug therapy,  immunology,  therapy*
Autoantibodies / immunology*
B-Lymphocytes / immunology*,  pathology
Cell Differentiation
Indoleamine-Pyrrole 2,3,-Dioxygenase / antagonists & inhibitors*
Lymphocyte Depletion / methods*
Mice
Mice, Transgenic
Recurrence / prevention & control
Tryptophan / analogs & derivatives*,  therapeutic use
Grant Support
ID/Acronym/Agency:
5-R01-AR-057847-01/AR/NIAMS NIH HHS; R01 AR057847/AR/NIAMS NIH HHS
Chemical
Reg. No./Substance:
0/1-methyltryptophan; 0/Autoantibodies; 0/Indoleamine-Pyrrole 2,3,-Dioxygenase; 73-22-3/Tryptophan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pre-neoplastic lesion, mucin-depleted foci, reveals de novo high-grade dysplasia in rat...
Next Document:  Virtual temporal bone dissection system: OSU virtual temporal bone system: development and testing.